Evidence map›Paper›PMID 27622544›Full record

Trial reportJournal of thrombosis and haemostasis : JTH2016

Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs.

J Bartko, C Schoergenhofer, M Schwameis, N Buchtele, J Wojta, G Schabbauer, L Stiebellehner, B Jilma

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of thrombosis and haemostasis : JTH, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs.Journal of thrombosis and haemostasis : JTH · 2016
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

J BartkoDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
C SchoergenhoferDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
M SchwameisDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
N BuchteleDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
J WojtaDepartment of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
G SchabbauerInstitute of Physiology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
L StiebellehnerDepartment of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
B JilmaDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essentials Glucocorticoids are associated with an increased risk of thrombosis. Healthy volunteers received dexamethasone or placebo in an endotoxin lung instillation model. Dexamethasone suppressed thrombin generation in bronchoalveolar lavage. Glucocorticoids inhibit endotoxin induced pulmonary coagulopathy. SUMMARY: Background Activation of local and systemic coagulation is a common finding in patients with pneumonia. There is evidence that glucocorticoids have procoagulant activity in the circulation, particularly in the context of inflammation. The effects of glucocorticoids on local pulmonary coagulation have not yet been investigated. Objective To use a human model of lung inflammation based on the local instillation of endotoxin in order to investigate whether glucocorticoids alter pulmonary coagulation. Methods Twenty-four healthy volunteers were randomized to receive either dexamethasone or placebo in a double-blind trial. Endotoxin was instilled via bronchoscope into right or left lung segments, followed by saline into the contralateral site. Six hours later, a bilateral bronchoalveolar lavage (BAL) was performed and coagulation parameters were measured. Results Endotoxin induced activation of coagulation in the bronchoalveolar compartment: the level of prothrombin fragment 1 + 2 (F

Indexed as

AdultAntithrombin IIIBlood CoagulationBlood Coagulation DisordersBronchoalveolar LavageBronchoalveolar Lavage FluidDexamethasoneDouble-Blind MethodEndotoxinsFemaleGlucocorticoidsHealthy VolunteersHumansInflammationLungMaleAntithrombin IIIantithrombin III-protease complexDexamethasoneEndotoxinsGlucocorticoidsPeptide Hydrolasesacute respiratory distress syndromecoagulationdexamethasonelungpneumonia

Identifiers

PMID27622544
PMCPMC5298044
OpenAlexW2518987184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.